TRIAL DETAIL
A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors |
|||
NCT#: |
||||
Conditions: |
Solid Tumors |
|||
Status: |
Active, not recruiting |
|||
Phase: |
1 |
Start Date 12/01/2016 |
Age of Trial (yrs) 7.8 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
SDH-directed |
|||
Strategy: |
Modify tumor microenvironment |
|||
Trial Type: |
GIST not specified. GIST patient enrollment unknown. |
|||
Other Protocol IDs: |
PT2977-101 |
|||
Sponsor: |
Peloton Therapeutics, Inc. |
|||
Patient Contact: |
Richard Kelley
972-629-4088
clinicalstudies@pelotontx.com |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
| PT2977 Poster from Peloton |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
1475 Northwest 12th Ave |
Miami |
FL |
33136 |
USA |
|
450 Brookline Ave |
Boston |
MA |
02215-5450 |
USA |
|
330 Brookline Ave. |
Boston |
MA |
02215 |
USA |
|
55 Fruit Street |
Boston |
MA |
02114 |
USA |
|
Medical Center Boulevard |
Winston-Salem |
NC |
27157 |
USA |
|
Nashville |
TN |
37203 |
USA |
||
4319 Medical Dr. |
San Antonio |
TX |
78229 |
USA |